CeriBellCBLL +1.20%12 Days Payable is 65.20 as of Mar. 2026, which is 76% above its 10-year median of 37.11. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, CeriBell ranks worse than 50.57% on this metric.
CeriBell's average Accounts Payable for the
three
months ended in Mar. 2026 was $2.41 Mil. CeriBell's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $3.37 Mil.
Hence, CeriBell's Days Payable for the
three
months ended in Mar. 2026 was 65.20.
The historical rank and industry rank for CeriBell's Days Payable or its related term are showing as below:
CBLL'
s Days Payable Range Over the Past 10 Years
Min: 29.85 Med: 37.11 Max: 67.59
Current: 67.59
During the past 4 years, CeriBell's highest Days Payable was 67.59. The lowest was 29.85. And the median was 37.11.
CBLL's Days Payable is ranked worse than 50.57% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs CBLL: 67.59
CeriBell's Days Payable
increased
from Mar. 2025 (46.16) to Mar. 2026 (65.20).
It may suggest that CeriBelldelayed paying its suppliers.
CeriBell Days Payable Related Terms
CeriBell Days Payable Historical Data
* Premium members only.
The historical data trend for CeriBell's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CeriBell's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CeriBell Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's Days Payable distribution charts can be found below:
* The bar in red indicates where CeriBell's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CeriBell's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CeriBell (CBLL) has a Days Payable of 65.20 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CeriBell and its competitors. This is 76% above median its historical median of 37.11. Over the past decade, CeriBell's Days Payable has ranged from 29.85 to 67.59. According to the industry distribution chart, CeriBell ranks #402 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 50.6%.
Is CeriBell's Days Payable too high?
CeriBell's current Days Payable of 65.20 is 76% above median its 10-year median of 37.11. Over the past 10 years, this metric has ranged from a low of 29.85 to a high of 67.59. The Medical Devices & Instruments industry median Days Payable is 67.87. CeriBell's value of 65.20 is 3.9% below this industry median. Based on the distribution chart, CeriBell ranks #402 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Days Payable compare to LMRI and SIBN?
According to the Medical Devices & Instruments industry distribution chart, CeriBell ranks #402 out of 795 companies for Days Payable. This places CeriBell in the lower half of its industry. The industry median Days Payable is 67.87. CeriBell's value of 65.20 is 3.9% below this benchmark. Historically, CeriBell's own Days Payable has ranged from 29.85 to 67.59 over the past decade. While the company's 10-year median is 37.11 vs. the industry median of 67.87, CeriBell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CeriBell's current Days Payable of 65.20 is 3.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CeriBell and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CeriBell's current Days Payable is 65.20, which is 76% above median its own 10-year median of 37.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Days Payable of 65.20. The current Days Payable is 65.20, which is 76% above median its 10-year median of 37.11 and 3.9% below the Medical Devices & Instruments industry median of 67.87. CeriBell's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CeriBell (CBLL), the current Days Payable is 65.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score
Get the complete analysis for CBLL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBLL has been successfully added to your 
